对人类ABCC4介导的血小板激动剂和对抗剂运输的结构洞察力
Yu Chen1,2,3, Liang Wang2,3, Wen-Tao Hou2,3
1Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Nature cardiovascular research
|August 28, 2024
概括
人类的ABC载体ABCC4通过运输激素和抗剂来调节血小板功能. 结构洞察力揭示了一个设计新型抗血小板药物的口袋,以预防心血管疾病.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 心血管科学 心血管科学
背景情况:
- 血小板对于静血和血栓形成至关重要;它们的失调有助于心血管疾病.
- 人类的ABC转运器ABCC4通过释放agonists和antagonists来影响血小板活动.
- 针对ABCC4提供了预防心血管疾病的潜在策略.
研究的目的:
- 阐明人类ABCC4.4的结构机制.
- 为了确定ABCC4.4的基质和抑制剂.
- 探索ABCC4作为新型抗血小板治疗的目标.
主要方法:
- 用X射线晶体学来确定人类ABCC4.4的五个不同的结构.
- 生物化学测试以验证基质和抑制剂相互作用.
- 结构分析以确定药物结合口袋.
主要成果:
- 定义了5个人类ABCC4结构,包括面向内面和面向外面的形状.
- U46619 (TXA2类似物) 和阿司匹林被确定为ABCC4基质.
- 迪皮里达摩尔被证实是ABCC4.4的强有力的竞争性抑制剂.
- 在ABCC4内发现了一个跨膜口袋.
结论:
- 人类的ABCC4在血小板功能调节中起着重要作用.
- 结构数据为理解ABCC4运输机制提供了基础.
- 已确定的跨膜口袋是针对特定的ABCC4抑制剂和血小板抗剂的合理药物设计的一个有希望的地点.
相关概念视频
ABC Transporters: Importer
2.7K
ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
2.7K
ABC Transporters: Exporter
4.2K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.2K
Carrier-Mediated Transport
316
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
316
Drug Binding to Blood Components
125
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
125
Hepatic Drug Clearance: Role of Transporters
44
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
44
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.6K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.6K


